328 related articles for article (PubMed ID: 6862729)
1. Bioavailability of sustained-release theophylline formulations.
Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
4. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
5. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
[TBL] [Abstract][Full Text] [Related]
6. The relation of product formulation to absorption of oral theophylline.
Weinberger M; Hendeles L; Bighley L
N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
[TBL] [Abstract][Full Text] [Related]
7. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
Karlsson S; Lührmann B; Bahner ML; Schulz HU
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739
[TBL] [Abstract][Full Text] [Related]
8. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
Mellstrand T; Svedmyr K; Svedmyr N
Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
[TBL] [Abstract][Full Text] [Related]
9. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
10. Theophylline bioavailability following oral administration of six sustained-release preparations.
Spangler DL; Kalof DD; Bloom FL; Wittig HJ
Ann Allergy; 1978 Jan; 40(1):6-11. PubMed ID: 623398
[TBL] [Abstract][Full Text] [Related]
11. HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state.
Mazzei M; Sottofattori E; Balbi A; Bottino GB
Farmaco; 1992 May; 47(5 Suppl):769-77. PubMed ID: 1524625
[TBL] [Abstract][Full Text] [Related]
12. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
Harrison LI; French IW; Mildon CA
Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982
[TBL] [Abstract][Full Text] [Related]
13. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
Bochsler HP; Meyer UA
Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
[TBL] [Abstract][Full Text] [Related]
14. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
15. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
16. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
18. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics and biologic availability of a new theophylline sustained-release preparation].
Brüller W; Fischer M; Tritthart W
Arzneimittelforschung; 1985; 35(12):1854-9. PubMed ID: 4096745
[TBL] [Abstract][Full Text] [Related]
20. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
